Clinical Trial Update: Weekly TP-HDFL in the Treatment of Advanced TCC [Phase 2]

View source ↗

Summary

This update reports a completed Phase 2 trial evaluating weekly TP-HDFL for advanced bladder cancer (transitional cell carcinoma).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer

Drugs mentioned

• TP-HDFL

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Transitional Cell Carcinoma | Phase 2 | Status: COMPLETED